Prevention of atherosclerosis in patients living with HIV

INVESTIGATIONAL PRODUCT: Rosuvastatin (Crestor(®); Astra Zeneca). ACTIVE INGREDIENTS: Rosuvastatin (5 mg). STUDY TITLE: Prevention of Atherosclerosis in Patients Living with HIV. PHASE OF STUDY: Phase III. AIMS: To assess whether rosuvastatin therapy could slow the progression of the carotid intima-...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lorenzo, Ferruccio, Boffito, Marta, Collot-Teixeira, Sophie, Gazzard, Brian, McGregor, John L, Shotliff, Kevin, Xiao, Han
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672452/
https://www.ncbi.nlm.nih.gov/pubmed/19436663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672452/
https://www.ncbi.nlm.nih.gov/pubmed/19436663

Ejemplares similares